317 related articles for article (PubMed ID: 26817504)
1. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.
Graff RE; Pettersson A; Lis RT; Ahearn TU; Markt SC; Wilson KM; Rider JR; Fiorentino M; Finn S; Kenfield SA; Loda M; Giovannucci EL; Rosner B; Mucci LA
Am J Clin Nutr; 2016 Mar; 103(3):851-60. PubMed ID: 26817504
[TBL] [Abstract][Full Text] [Related]
2. A comparison of plasma and prostate lycopene in response to typical servings of tomato soup, sauce or juice in men before prostatectomy.
Grainger EM; Hadley CW; Moran NE; Riedl KM; Gong MC; Pohar K; Schwartz SJ; Clinton SK
Br J Nutr; 2015 Aug; 114(4):596-607. PubMed ID: 26202168
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of lycopene and tomato product intake and risk of prostate cancer.
Kirsh VA; Mayne ST; Peters U; Chatterjee N; Leitzmann MF; Dixon LB; Urban DA; Crawford ED; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):92-8. PubMed ID: 16434593
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of tomato products, lycopene, and prostate cancer risk.
Giovannucci E; Rimm EB; Liu Y; Stampfer MJ; Willett WC
J Natl Cancer Inst; 2002 Mar; 94(5):391-8. PubMed ID: 11880478
[TBL] [Abstract][Full Text] [Related]
5. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma.
Kim HS; Bowen P; Chen L; Duncan C; Ghosh L; Sharifi R; Christov K
Nutr Cancer; 2003; 47(1):40-7. PubMed ID: 14769536
[TBL] [Abstract][Full Text] [Related]
6. The prognostic and predictive value of TMPRSS2-ERG gene fusion and ERG protein expression in prostate cancer biopsies.
Berg KD
Dan Med J; 2016 Dec; 63(12):. PubMed ID: 27910803
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.
Pernar CH; Ebot EM; Pettersson A; Graff RE; Giunchi F; Ahearn TU; Gonzalez-Feliciano AG; Markt SC; Wilson KM; Stopsack KH; Gazeeva E; Lis RT; Parmigiani G; Rimm EB; Finn SP; Giovannucci EL; Fiorentino M; Mucci LA
Eur Urol; 2019 Jul; 76(1):33-40. PubMed ID: 30301696
[TBL] [Abstract][Full Text] [Related]
8. Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies.
Chen J; Song Y; Zhang L
J Nutr Sci Vitaminol (Tokyo); 2013; 59(3):213-23. PubMed ID: 23883692
[TBL] [Abstract][Full Text] [Related]
9. Height, Obesity, and the Risk of
Graff RE; Ahearn TU; Pettersson A; Ebot EM; Gerke T; Penney KL; Wilson KM; Markt SC; Pernar CH; Gonzalez-Feliciano AG; Song M; Lis RT; Schmidt DR; Vander Heiden MG; Fiorentino M; Giovannucci EL; Loda M; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):193-200. PubMed ID: 29167279
[No Abstract] [Full Text] [Related]
10. Intake of carotenoids and retinol in relation to risk of prostate cancer.
Giovannucci E; Ascherio A; Rimm EB; Stampfer MJ; Colditz GA; Willett WC
J Natl Cancer Inst; 1995 Dec; 87(23):1767-76. PubMed ID: 7473833
[TBL] [Abstract][Full Text] [Related]
11. Tomato products, lycopene, and prostate cancer risk.
Miller EC; Giovannucci E; Erdman JW; Bahnson R; Schwartz SJ; Clinton SK
Urol Clin North Am; 2002 Feb; 29(1):83-93. PubMed ID: 12109359
[TBL] [Abstract][Full Text] [Related]
12. Liquid chromatography-mass spectrometry of cis- and all-trans-lycopene in human serum and prostate tissue after dietary supplementation with tomato sauce.
van Breemen RB; Xu X; Viana MA; Chen L; Stacewicz-Sapuntzakis M; Duncan C; Bowen PE; Sharifi R
J Agric Food Chem; 2002 Apr; 50(8):2214-9. PubMed ID: 11929273
[TBL] [Abstract][Full Text] [Related]
13. The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.
Pettersson A; Graff RE; Bauer SR; Pitt MJ; Lis RT; Stack EC; Martin NE; Kunz L; Penney KL; Ligon AH; Suppan C; Flavin R; Sesso HD; Rider JR; Sweeney C; Stampfer MJ; Fiorentino M; Kantoff PW; Sanda MG; Giovannucci EL; Ding EL; Loda M; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1497-509. PubMed ID: 22736790
[TBL] [Abstract][Full Text] [Related]
14. V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application.
Park K; Chiu YL; Rubin MA; Demichelis F; Mosquera JM
Hum Pathol; 2013 Oct; 44(10):2282-92. PubMed ID: 23856515
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
Setlur SR; Mertz KD; Hoshida Y; Demichelis F; Lupien M; Perner S; Sboner A; Pawitan Y; Andrén O; Johnson LA; Tang J; Adami HO; Calza S; Chinnaiyan AM; Rhodes D; Tomlins S; Fall K; Mucci LA; Kantoff PW; Stampfer MJ; Andersson SO; Varenhorst E; Johansson JE; Brown M; Golub TR; Rubin MA
J Natl Cancer Inst; 2008 Jun; 100(11):815-25. PubMed ID: 18505969
[TBL] [Abstract][Full Text] [Related]
16. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
Tsourlakis MC; Weigand P; Grupp K; Kluth M; Steurer S; Schlomm T; Graefen M; Huland H; Salomon G; Steuber T; Wilczak W; Sirma H; Simon R; Sauter G; Minner S; Quaas A
Am J Pathol; 2014 Mar; 184(3):609-17. PubMed ID: 24378408
[TBL] [Abstract][Full Text] [Related]
17. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer.
Graff RE; Pettersson A; Lis RT; DuPre N; Jordahl KM; Nuttall E; Rider JR; Fiorentino M; Sesso HD; Kenfield SA; Loda M; Giovannucci EL; Rosner B; Nguyen PL; Sweeney CJ; Mucci LA;
Prostate; 2015 Jun; 75(9):897-906. PubMed ID: 25728532
[TBL] [Abstract][Full Text] [Related]
18. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer.
Giovannucci E
Exp Biol Med (Maywood); 2002 Nov; 227(10):852-9. PubMed ID: 12424325
[TBL] [Abstract][Full Text] [Related]
19. Lycopene, tomato products and prostate cancer-specific mortality among men diagnosed with nonmetastatic prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Wang Y; Jacobs EJ; Newton CC; McCullough ML
Int J Cancer; 2016 Jun; 138(12):2846-55. PubMed ID: 26830232
[TBL] [Abstract][Full Text] [Related]
20. Marked heterogeneity of ERG expression in large primary prostate cancers.
Minner S; Gärtner M; Freudenthaler F; Bauer M; Kluth M; Salomon G; Heinzer H; Graefen M; Bokemeyer C; Simon R; Sauter G; Schlomm T; Wilczak W
Mod Pathol; 2013 Jan; 26(1):106-16. PubMed ID: 22899295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
